Surgery Partners Group - SGRY Enterprise Value to EBITDA Ratio
Surgery Partners, Inc. (SGRY) is scaling its center network through M&A and robotics, a strategy validated by its EV/EBITDA multiple valuation. The current 14.32 reflects the state of this metric. A steady stream of insurance reimbursements ensures resilient cash flows regardless of economic cycles. Experienced management is effectively capitalizing on the shift of surgery toward the outpatient segment, maintaining high business margins.
Comprehensive metric breakdowns and analytics for surgerypartners.com (SGRY)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Debt to Equity Surgery Partners, Inc.|SGRY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Surgery Partners|SGRY - Company Total Indebtedness|Debts to Book Capitalization Surgery Partners Group|SGRY - Long-Term Debt|Company Short-Term Debt Surgery Partners|Quick Liquidity Indicator surgerypartners.com
- business earnings and investment ratios data:
SGRY - Company Net Income|Future Profit Surgery Partners, Inc.|SGRY - Company Value to Net Income|Future Price to Earnings Surgery Partners, Inc.|SGRY - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Surgery Partners Group|SGRY - Operating profit EBITDA|Earnings per share for the last twelve months Surgery Partners|SGRY - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months surgerypartners.com|SGRY - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Surgery Partners, Inc.
Basic company analysis:Surgery Partners Corp SGRY
Scaling the Surgery Partners, Inc. (SGRY) network of ambulatory centers through acquisitions requires significant capital expenditures, making the debt load a critical valuation factor. The current EV/EBITDA multiple compares the total enterprise value to operating profit, allowing investors to strip out the impact of taxes and interest to determine whether the downward trend on the chart signals an undervalued asset or a systemic decline in clinic margins.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|UHS - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio DVA|EV/EBITDA Multiple RadNet Management|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Option Care Health (OPCH)|PINC (premierinc.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple EYE (National Vision)|Enterprise Value to EBITDA Multiple Progyny Inc|Ardent Health Partners Inc - EV/EBITDA Multiple|Company Value to EBITDA Select Medical Inc.|Astrana Health, Inc. (ASTH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Pediatrix Medical Group - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio USPH|Company Value to EBITDA Pennant Group PNTG|Enterprise Value to EBITDA Ratio ORGO (Organogenesis Inc.)|NUTX (Nutex Health Hospitals) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Auna SA AUNA|SBC (sbc-holdings.com) - Company Value to Operating Income Before Depreciation Ratio|Evolus - EV/EBITDA Multiple|CYH - EV/EBITDA Multiple|beautyhealth.com (SKIN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MediWound - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio BTMD|JYNT (thejoint.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|p3hp.org - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple GANX (Gain Therapeutics, Inc.)|euda.com (EUDA) - Company Value to EBITDA|BMGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CLGN (CollPlant Biotechnologies)|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CCM - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio AMS|MRM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ALBT|Total Company Value to Operating Income Before Depreciation Ratio dih.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carmell Therapeutics XAGE|NIVF: Enterprise Value to Operating Income Before Depreciation|ATI Physical Therapy Corp - EV/EBITDA Multiple|CareMax, Inc (CMAX) - Enterprise Value to EBITDA Ratio|KDLY (Kindly MD, Inc.) - Enterprise Value to EBITDA Ratio|MODV - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Novo Integrated Sciences, Inc.|SunLink Health Systems, Inc (SSY) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple BACK
